Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

AstraZeneca has a heritage in respiratory medicine, but has not produced any new products in the field for ... combinations delivered via dry powder inhaler and metered dose inhaler devices.

AstraZeneca and Novo Nordisk ... warning letters – aimed at manufacturers of asthma inhalers, epinephrine autoinjectors, and other drug products – challenging around 100 patents a few weeks ...

For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all ...

Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...

Whereas the latter derives most of its revenue from a few diabetes or obesity drugs, AstraZeneca has a large and diversified pipeline of medicines. The company's products span the field of ...

Our guide to upcoming products provides an overview of all of the new devices that we're expecting to see in 2025, based on the most current rumors. The dates listed here are not always concrete ...

Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...

a U.S. affiliate of T Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinicsThe program, launching this month, will run for a minimum of three ...

NMRA and HOTH are in the spotlight in the biotech sector on study data announcement. Catalyst stock gains 17% as it settles Firdapse patent litigation with Teva protecting the drug's exclusivity in ...

AstraZeneca Pharma India Ltd. key Products/Revenue Segments include Pharmaceuticals and Sale of services for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a ...